The Chennai High Court on Tuesday allowed local drug-makers to sell two medicines banned by the Indian government for another four weeks, acting on a plea of small pharmaceutical companies that can now exhaust those products with their stockists and chemists.
The court order has temporarily stayed the ban on sale of nimesulide for use by children below 12 years and nasal congestion drug phenylpropanolamine (PPA) that have combined sales of about Rs 30-40 crore a year, said T S Jaishankar, chairman at industry body representing small drug-makers Confederation of Indian Pharmaceutical Industry .
However, companies cannot dispatch new batches or resume production. The association will now move the court to remove the ban on the drugs altogether.
On February 10, the government had prohibited sale and manufacture of gastrointestinal drug cisapride and medicines made from human placental extract, besides the two medicines immediately due to adverse side effects.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment